Case
Age/Sex
Baseline eGFR*
Time to AKI (Days)
Duration of AKI (Days)
KDIGO stage#
Management during AKI
Laboratory findings during AKI
Laboratory findings during AKI
Laboratory findings during AKI
Laboratory findings during AKI
Laboratory findings during AKI
Laboratory findings during AKI
Laboratory findings during AKI
Diagnosis of AKI
Anti-TB regimen after AKI
Renal recovery
Worst eGFR*
Urine WBC
Urine RBC
Urine protein
Renal echography
FENA (%)
RBC Morphology
1 50s/M 172 56 217 1 Observation 100 2-5 0-1 Trace Enlarged kidneys 0.2% Anisocytosis Prerenal HREZ Yes
2 70s/M 164 56 269 1 Hold HREZ 83 0-2 0-2 - Renal stone 1.2% Teardrop cell Intrinsic HREZ Yes
3 60s/M 139 47 49 1 Hold HREZ 81 0-2 0-2 Trace Parenchymal renal disease 1.1% Anisocytosis Intrinsic HRZ Yes
4 40s/F 124 68 8 3 Hold HREZ 9 5-10 5-10 - Normal 0.5% Anisocytosis Prerenal HRE Yes
5 60s/F 123 35 56 1 Hold HREZ 55 0-2 0-2 - Parenchymal renal disease 1.1% Anisocytosis Intrinsic HRE Yes
6 40s/F 110 11 15 1 Observation 69 0-2 0-1 - Normal 1.4% Normal Intrinsic HREZ Yes
7 40s/F 108 6 10 1 Observation 50 0-2 0-2 - Parenchymal renal disease 2.9% Anisocytosis Intrinsic HREZ Yes
8 70s/M 90 39 27 1 Hold E 49 0-2 10-25 Trace Enlarged left kidney 0.6% Target cells Prerenal HREZ Yes
9 70s/F 82 44 286 1 Hold HREZ 54 2-5 2-5 1+ Parenchymal renal disease 0.5% Anisocytosis, fragment RBC Prerenal HREZ Yes
10 80s/M 71 14 14 1 Observation 52 0-2 5-10 1+ Left kidney atrophy 0.6% Anisocytosis Prerenal HREZ Yes
11 70s/M 48 11 29 1 Hold HREZ 37 0-2 0-2 Trace Renal stone 1.1% Anisocytosis Intrinsic HREZ Yes